CATHLEEN CHIDESTER: Open Payments
NPI 1134109432 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 13 payments from 6 companies in 2025. Trend: 2023 $81 · 2024 $0 · 2025 $351
Food & beverage: $279Education: $72
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $182 |
| Novartis Pharmaceuticals Corporation | 1 | $109 |
| Galderma Laboratories, L.P. | 1 | $21 |
| GENZYME CORPORATION | 1 | $20 |
| PFIZER INC. | 1 | $16 |
| Organon LLC | 1 | $3 |
Products named: TREMFYA, Rhapsido, NEMLUVIO, DUPIXENT, CIBINQO.
Industry payments across TX — which companies pay providers there.
